Pfenex Inc (PFNX) Return on Investment ROI from the second quarter of 2020 to second quarter of 2019 and for the year 2020, average high and low, overall ranking from Jun 30 2020 to Jun 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Pfenex Inc   (NYSEAMER: PFNX)


Pfenex Inc's ROI from its second quarter of 2020 to the second quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Pfenex Inc's ROI in the second quarter of 2020?
Pfenex Inc recorded a cumulative net loss of $-6 million during 12 months ending in the second quarter of 2020, resulting in a negative return on investment (ROI) of -8%.

Within the Healthcare sector 264 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2020 from 0 to 3113.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter
Y / Y Investment Change TTM 15.55 % -2.43 % -6.38 % -8.6 % 1.99 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 74 83 72 58 54
Return On Investment (TTM) -8 % -4.57 % 1.67 % -29.33 % -49.99 %
PFNX's Overall Ranking # 3113 # 0 # 2392 # 0 # 0
Seq. Investment Change TTM 7.43 % 8.98 % 3.57 % -4.7 % -9.29 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -6 -3 1 -17 -31

PFNX Company Profile >> Back to PFNX Roi Comparisons >> See Annual PFNX Return On Investment



Return On Investment PFNX's Ranking
Within: No.
Industry # 89
Sector # 265
Overall # 3113

Return On Investment Statistics
High Average Low
26.41 %
-31.65 %
-118.49 %
(Mar 31 2015)   (Mar 31 2018)







Financial Statements
Pfenex Inc's II. Quarter Investments $ 74 Millions PFNX's Balance sheet
Pfenex Inc's II. Quarter Income $ -10 Millions Quarterly PFNX's Income Statement
PFNX's Income by Division See PFNX's Income by Division


PFNX Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions 72 64 61 86 115
Y / Y Investment Growth 13.31 % 4.77 % -29.08 % -25.59 % 82.54 %
Net Income in Millions 1 -40 -26 5 -28
Y / Y Net Income Growth - - - - -
Annual Return On Investment 1.46 % -62.03 % -42.16 % 6.38 % -24.44 %


Annual Roi Comment
In the fiscal year 2019 ROI improved to 1.46 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PFNX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PFNX's Competitors
Subscribers only: Roi for Pfenex Inc's Suppliers
Subscribers only: Return On Investment for PFNX's Customers

Other Ratios
PFNX's Roa PFNX's Inventory Turnover Ratio PFNX's Growth Rates PFNX's Dividend Statistics
PFNX's Profitability Ratios PFNX's Asset Turnover Ratio PFNX's Dividend Growth
PFNX's Roe PFNX's Valuation Ratios PFNX's Financial Strength Ratios PFNX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2020, within Healthcare Sector ROI

Date modified: 2026-08-29T17:23:09+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.